Related Experiment Video

Updated: May 15, 2026

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

Cardiac period 2 in myocardial ischemia: clinical implications of a light dependent protein

Stephanie Bonney1, Kelly Hughes, Patrick N Harter

  • 1Department of Anesthesiology and Mucosal Inflammation Program, University of Colorado Denver, CO, USA.

The International Journal of Biochemistry & Cell Biology
|January 8, 2013
PubMed

Insights

Circadian rhythm protein Period 2 (Per2) protects the heart from ischemia, especially when exposed to daylight. Targeting cardiac Per2 may benefit cardiovascular health.

Area of Science:

  • Cardiovascular disease research
  • Chronobiology and heart health

Background:

  • Cardiovascular diseases like myocardial infarction and stroke exhibit distinct circadian patterns.
  • Disrupted circadian rhythms are implicated in cardiovascular disease development.
  • Myocardial ischemia severity is influenced by the time of day it occurs.

Purpose of the Study:

  • To investigate the cardioprotective role of the circadian rhythm protein Period 2 (Per2) in myocardial ischemia.
  • To explore the link between sunlight exposure, cardiac Per2, and cardiovascular protection.
  • To connect current research on circadian rhythm proteins to potential clinical applications for cardiovascular disease.

Main Methods:

  • Studied the effect of daylight exposure on cardiac Per2 levels in mice.
  • Assessed the association between induced cardiac Per2 and protection from myocardial ischemia in a mouse model.
  • Reviewed epidemiological and clinical studies on circadian rhythms and cardiovascular health.

Main Results:

  • Exposure to daylight induced cardiac Per2 in mice.
  • Induced cardiac Per2 was associated with protection against myocardial ischemia.
  • Sunlight is a key regulator of the human circadian rhythm, vital for cardiovascular health.

Conclusions:

  • The circadian rhythm protein Per2 plays a cardioprotective role during myocardial ischemia.
  • Daylight-induced Per2 offers protection against cardiac ischemia.
  • Targeting cardiac Per2 presents a potential future clinical strategy for cardiovascular disease management.

More Related Videos

Optical Imaging of Isolated Murine Ventricular Myocytes11:32

Optical Imaging of Isolated Murine Ventricular Myocytes

Published on: January 17, 2020

Local Field Fluorescence Microscopy: Imaging Cellular Signals in Intact Hearts10:33

Local Field Fluorescence Microscopy: Imaging Cellular Signals in Intact Hearts

Published on: March 8, 2017

Related Concept Videos

Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...